Otsuka Beverage established the factory and transferred it to Otsuka Pharmaceutical in 2008. It produces mainly POCARI SWEAT.
NC
Taiwan Otsuka Beverage Co., Ltd. (now King Car Otsuka Co., Ltd.) established in Taiwan
1997
Ph
Otsuka (Philippines) Pharmaceutical, Inc. established
NC
Otsuka Pharmaceutical (H.K.) Ltd. established in Hong Kong
PT Kapal Indah Otsuka (now PT Amerta Indah Otsuka) established in Indonesia
1998
Ph
Otsuka Pharmaceutical Europe Ltd. established in U.K.
The beginning of the growth era in Otsuka's European business
U.S.-based Cambridge Isotope Laboratories, Inc. joined the Otsuka group
1999
Corp
Tokushima Itano Factory completed
The Tokushima Itano Factory began as a pharmaceuticals production site and currently also produces nutraceutical products.
Ph
Global alliance on ABILIFY with Bristol-Myers Squibb Company
A co-development and co-marketing contract was signed with Bristol-Myers Squibb Company for the antipsychotic ABILIFY (aripiprazole) globally.
2000
Ph
UBIT launched
Diagnostic agent for H. pylori infection
NC
Otsu Research Institute (now Nutraceuticals Research Institute (Otsu research site)) established
2001
Corp
Otsuka International Asia Arab (OIAA) Division established
The OIAA Division was established to build a strong and integrated business foundation for group companies in these regions, with a new perspective and accelerated decision-making.
2002
Ph
ABILIFY launched in the U.S.
Antipsychotic drug (Launched in Japan in 2006.)
NC
Tianjin Otsuka Beverage Co., Ltd. established in China
2003
Ph
Otsuka (China) Investment Co., Ltd. and Otsuka Beijing Research Institute established
